Publication | Closed Access

Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults

VaccinologyVaccine SafetyCross-protectionVaccinationImmunologyVaccine EfficacyInfluenza VaccineOlder AdultsPolyvalent VaccineMedicineEgg-based Vaccine ProductionInfluenza Vaccines